project id: TCGA-BLCA; case submitter id: TCGA-2F-A9KO; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.91; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.53; rna integrity number: 7.2; age at index: 63; days to birth: -23323; days to death: 734; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1945; age at diagnosis: 23323; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 678.0; icd 10 code: C67.4; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Posterior wall of bladder; synchronous malignancy: No; tissue or organ of origin: Posterior wall of bladder; tumor grade: Not Reported; year of diagnosis: 2008; alcohol history: Not Reported; cigarettes per day: 3.780821917808219; pack years smoked: 69.0; is ffpe: false; composition: Not Reported; days to collection: 2168; days to sample procurement: 0; specimen type: Solid Tissue; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent stromal cells: 0.0;